The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.
 
David Lavie
Consulting or Advisory Role - Abbvie; Novartis; Takeda
 
John Timmerman
Honoraria - Kite/Gilead
Consulting or Advisory Role - DAVA Oncology; Kite/Gilead; Oncovalent Therapeutics; Oncovalent Therapeutics
Research Funding - Bristol-Myers Squibb; Kite, a Gilead company; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ramón Garcia Sanz
Honoraria - Amgen; AstraZeneca Spain; Beigene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Janssen
Research Funding - Astellas Pharma; Incyte (Inst); Takeda (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - BIOMED 2 primers (Inst)
Travel, Accommodations, Expenses - Janssen; Takeda (I)
Other Relationship - Spanish Society of Hematology
 
Won Seog Kim
Research Funding - BeiGene; Boryung; Dong-A Pharm; Kyowa Kirin; Roche; Sanofi
 
Tae Min Kim
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda; Yuhan
Speakers' Bureau - IMBdx; Janssen Research & Development; Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Boryung; Novartis; Roche/Genentech
 
Abraham Avigdor
Honoraria - Abbvie
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Roche
 
Daan Dierickx
Honoraria - Atara Biotherapeutics; Genzyme; Incyte; Pierre Fabre; Takeda
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Genzyme; Incyte; Novartis; Roche; Takeda
 
Deepa Jagadeesh
Consulting or Advisory Role - AFM; Daiichi Sankyo/Lilly; Genmab
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); MEI Pharma (Inst); Merck (Inst); Regeneron (Inst); Rhizen Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Daniel Molin
Honoraria - Bristol-Myers Squibb; Merck; Roche; Takeda
 
Muhit Ozcan
Research Funding - Abbvie; Acerta Pharma/AstraZeneca; Bayer; Dr. Reddy's Laboratories; Janssen; Merck; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Jazz Pharmaceuticals; Roche
 
Ömür Gökmen Sevindik
No Relationships to Disclose
 
Hayder Saeed
Consulting or Advisory Role - Cardinal Health; Epizyme; Genzyme; MorphoSys; Seagen
 
Yulia Sidi
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Pallavi Pillai
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Patricia Marinello
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb